Drug comparisons
Canagliflozin vs Tolbutamide
Compare Canagliflozin and Tolbutamide, oral drugs for type 2 diabetes. SGLT2 inhibitor vs sulfonylurea: key differences in action, benefits, and risks.
No comparison dimensions are available for this page.
Clinical context
This comparison arises for type 2 diabetes patients considering newer SGLT2 inhibitors over older first-generation sulfonylureas.
Bottom line
Canagliflozin generally offers more benefits than Tolbutamide for most eligible type 2 diabetes patients.
All medication comparisons